Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024

Union Korea Pharm Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Operating Revenue
33,83151,28063,16961,29348,30450,379
Upgrade
Other Revenue
-0--0---
Upgrade
Revenue
33,83151,28063,16961,29348,30450,379
Upgrade
Revenue Growth (YoY)
-47.22%-18.82%3.06%26.89%-4.12%-1.73%
Upgrade
Cost of Revenue
32,54637,15642,38837,37733,15431,113
Upgrade
Gross Profit
1,28514,12420,78123,91715,15019,267
Upgrade
Selling, General & Admin
20,42927,58724,67522,14723,98724,077
Upgrade
Research & Development
781.421,027833.33922.152,451988.78
Upgrade
Amortization of Goodwill & Intangibles
115.86301.46311.24350.72368.82366.77
Upgrade
Other Operating Expenses
266.56264.02244.29294.22196.45190.14
Upgrade
Operating Expenses
29,13332,73435,46322,64625,76430,098
Upgrade
Operating Income
-27,848-18,610-14,6821,271-10,615-10,832
Upgrade
Interest Expense
-2,668-3,920-4,112-2,843-2,229-667.41
Upgrade
Interest & Investment Income
29.5697.74105.4347.6146.6440.06
Upgrade
Earnings From Equity Investments
-33.18-23.89-19.46-5.47-9.49-
Upgrade
Currency Exchange Gain (Loss)
22.0889.979.98-55.1496.43-108.66
Upgrade
Other Non Operating Income (Expenses)
3,1197,2641,6952,528-1,628-210.37
Upgrade
EBT Excluding Unusual Items
-27,379-15,102-17,004943.54-14,338-11,778
Upgrade
Gain (Loss) on Sale of Assets
35.240.67129.04-7.54-306.31
Upgrade
Asset Writedown
-----146.73-
Upgrade
Other Unusual Items
-1,127-3,8262,471---
Upgrade
Pretax Income
-28,470-18,928-14,404943.54-14,477-12,084
Upgrade
Income Tax Expense
1,9471,9443,7531,876-3,367-2,762
Upgrade
Net Income
-30,417-20,872-18,156-932.02-11,109-9,322
Upgrade
Net Income to Common
-30,417-20,872-18,156-932.02-11,109-9,322
Upgrade
Shares Outstanding (Basic)
777787
Upgrade
Shares Outstanding (Diluted)
777787
Upgrade
Shares Change (YoY)
5.95%0.10%-2.14%-5.05%16.95%12.55%
Upgrade
EPS (Basic)
-4089.88-2887.58-2514.45-126.31-1429.59-1430.75
Upgrade
EPS (Diluted)
-4090.29-2888.00-2514.45-126.31-1430.00-1430.75
Upgrade
Free Cash Flow
178.83-534.23-901.15-8,429-5,254-10,039
Upgrade
Free Cash Flow Per Share
24.05-73.91-124.80-1142.33-676.09-1510.90
Upgrade
Gross Margin
3.80%27.54%32.90%39.02%31.36%38.24%
Upgrade
Operating Margin
-82.31%-36.29%-23.24%2.07%-21.98%-21.50%
Upgrade
Profit Margin
-89.91%-40.70%-28.74%-1.52%-23.00%-18.50%
Upgrade
Free Cash Flow Margin
0.53%-1.04%-1.43%-13.75%-10.88%-19.93%
Upgrade
EBITDA
-25,783-15,733-10,7925,266-6,389-7,084
Upgrade
EBITDA Margin
-76.21%-30.68%-17.08%8.59%-13.23%-14.06%
Upgrade
D&A For EBITDA
2,0652,8773,8903,9944,2263,747
Upgrade
EBIT
-27,848-18,610-14,6821,271-10,615-10,832
Upgrade
EBIT Margin
-82.31%-36.29%-23.24%2.07%-21.98%-21.50%
Upgrade
Effective Tax Rate
---198.78%--
Upgrade
Advertising Expenses
-302.811,984865.841,0901,618
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.